Bill > HB2107

This bill authorizes certain universities, institutions of higher education, and research facilities in Oklahoma to conduct scientific research and clinical trials related to psilocybin and psilocyn, which are controlled dangerous substances. The bill establishes the Oklahoma Psilocybin Research Pilot Program, requiring registration with state agencies, payment of fees, and issuance of written certifications for participants. It provides immunities from prosecution for researchers, physicians, and patients complying with the program's provisions. The bill also requires the submission of written reports on the study results and recommendations, and it addresses confidentiality of personal information and the promulgation of rules to implement the program. Additionally, the bill amends the state's Uniform Controlled Dangerous Substances Act to include a registration fee for researchers of psilocybin or psilocyn.